+

WO2018144093A3 - Formulations pour soins de la peau améliorés - Google Patents

Formulations pour soins de la peau améliorés Download PDF

Info

Publication number
WO2018144093A3
WO2018144093A3 PCT/US2017/059960 US2017059960W WO2018144093A3 WO 2018144093 A3 WO2018144093 A3 WO 2018144093A3 US 2017059960 W US2017059960 W US 2017059960W WO 2018144093 A3 WO2018144093 A3 WO 2018144093A3
Authority
WO
WIPO (PCT)
Prior art keywords
hyaluronic acid
collagen
formulations
skin care
improved skin
Prior art date
Application number
PCT/US2017/059960
Other languages
English (en)
Other versions
WO2018144093A2 (fr
Inventor
Mark A. Pinsky
Original Assignee
Pinsky Mark A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pinsky Mark A filed Critical Pinsky Mark A
Publication of WO2018144093A2 publication Critical patent/WO2018144093A2/fr
Publication of WO2018144093A3 publication Critical patent/WO2018144093A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/001—Preparations for care of the lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne des compositions et des procédés d'administration de collagène et/ou d'acide hyaluronique à un sujet humain. Les vésicules lipidiques contenant du collagène et/ou de l'acide hyaluronique de l'invention fournissent un système d'administration de protéine de collagène et/ou d'acide hyaluronique qui améliore significativement l'état de la peau d'un sujet humain tout en éliminant les problèmes associés à l'instabilité chimique et physique du collagène et/ou de l'acide hyaluronique ainsi que des réponses immunitaires associées.
PCT/US2017/059960 2016-11-03 2017-11-03 Formulations pour soins de la peau améliorés WO2018144093A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662416987P 2016-11-03 2016-11-03
US62/416,987 2016-11-03

Publications (2)

Publication Number Publication Date
WO2018144093A2 WO2018144093A2 (fr) 2018-08-09
WO2018144093A3 true WO2018144093A3 (fr) 2019-03-07

Family

ID=63040032

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/059960 WO2018144093A2 (fr) 2016-11-03 2017-11-03 Formulations pour soins de la peau améliorés

Country Status (1)

Country Link
WO (1) WO2018144093A2 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9895359B1 (en) 2017-06-07 2018-02-20 Arcutis, Inc. Inhibition of crystal growth of roflumilast
US11129818B2 (en) 2017-06-07 2021-09-28 Arcutis Biotherapeutics, Inc. Topical roflumilast formulation having improved delivery and plasma half life
US12011437B1 (en) 2017-06-07 2024-06-18 Arcutis Biotherapeutics, Inc. Roflumilast formulations with an improved pharmacokinetic profile
US20210161870A1 (en) 2017-06-07 2021-06-03 Arcutis Biotherapeutics, Inc. Roflumilast formulations with an improved pharmacokinetic profile
AU2019281888B2 (en) 2018-06-04 2024-05-02 Arcutis Biotherapeutics, Inc. Method and formulation for improving roflumilast skin penetration lag time
KR102529881B1 (ko) * 2019-04-01 2023-05-04 젤터, 인코포레이티드 재조합 콜라겐의 국소 제제
CA3136691A1 (fr) 2019-04-12 2020-10-15 Geltor, Inc. Elastine de recombinaison et production associee
US11786451B2 (en) 2019-06-28 2023-10-17 The Procter & Gamble Company Skin care composition
US20200405621A1 (en) * 2019-06-28 2020-12-31 The Procter & Gamble Company Skin Care Composition
KR20220100850A (ko) * 2019-07-26 2022-07-18 판도럼 테크놀로지스 프라이뱃 리미티드 생체공학적 제형, 이의 제조 및 구현 공정
WO2021018377A1 (fr) * 2019-07-29 2021-02-04 Giuliani S.P.A. Composition cosmétique à charge combinée et effet régénérateur cutané
KR20220070246A (ko) 2019-09-23 2022-05-30 디디에스 리서치 인크. 침투 증진제를 갖는 지질 소포 조성물
CN111036156A (zh) * 2020-01-14 2020-04-21 江苏罗格斯生物科技有限公司 一种绿色功能因子精准控制材料的制备方法
CN111281840B (zh) * 2020-02-13 2022-03-29 广州伊尔美生物科技有限公司 一种亮颜美肤霜及其制备方法
AU2021268977B2 (en) * 2020-05-07 2024-05-23 Arcutis Biotherapeutics, Inc. Treatment of skin conditions using high Krafft temperature anionic surfactants
CN111494233B (zh) * 2020-06-02 2023-07-14 康珞生物科技（武汉）有限公司 一种胶原短肽脂质体的制备方法及应用
CN112057351B (zh) * 2020-09-22 2023-01-24 西安诗莱梦特生物科技有限公司 透明质酸-羟丙基甲基纤维素复合水凝胶及其制备方法和应用
EP4221679A4 (fr) * 2020-09-30 2025-03-26 Geltor Inc Compositions comprenant des combinaisons de polypeptides de collagène ou d'élastine avec des principes actifs et leurs procédés d'utilisation
CN114246818A (zh) * 2021-03-08 2022-03-29 山东祥隆医药研究院有限公司 一种具有防敏、保湿、修复功效的精华乳及其制备方法
WO2022204287A1 (fr) * 2021-03-24 2022-09-29 Glo Pharma, Inc. Vésicules lipidiques multisomes pour l'administration d'agents cosmétiques
EP4313100A2 (fr) 2021-03-24 2024-02-07 GLO Pharma, Inc. Peptides et procédés de réduction de la pigmentation de la peau
AU2023342481A1 (en) 2022-09-15 2025-04-10 Arcutis Biotherapeutics, Inc. Pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the drug
CN116617146B (zh) * 2023-05-26 2024-12-17 广东巴松那生物科技有限公司 一种用于修复激素脸的护肤霜及其制备方法
CN117017869B (zh) * 2023-09-15 2024-01-30 名宇(广东)化妆品科技有限公司 一种美白祛斑霜及制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846561A (en) * 1991-02-14 1998-12-08 Baxter International Inc. Method of binding collagen recognizing substances to liposomes
US6992172B1 (en) * 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
US20100221319A1 (en) * 2005-10-03 2010-09-02 Pinsky Mark A Compositions and Methods for Improved Skin Care
KR20110036664A (ko) * 2009-10-02 2011-04-08 가부시키가이샤 페이스 콜라겐 수식 리포솜으로 이루어지는 화장료 기제 및 그것을 함유하는 피부 화장료
CN102988200A (zh) * 2012-12-10 2013-03-27 北京莱米瑞克科技发展有限公司 脂质体养颜护肤品

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846561A (en) * 1991-02-14 1998-12-08 Baxter International Inc. Method of binding collagen recognizing substances to liposomes
US6992172B1 (en) * 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
US20100221319A1 (en) * 2005-10-03 2010-09-02 Pinsky Mark A Compositions and Methods for Improved Skin Care
KR20110036664A (ko) * 2009-10-02 2011-04-08 가부시키가이샤 페이스 콜라겐 수식 리포솜으로 이루어지는 화장료 기제 및 그것을 함유하는 피부 화장료
CN102988200A (zh) * 2012-12-10 2013-03-27 北京莱米瑞克科技发展有限公司 脂质体养颜护肤品

Also Published As

Publication number Publication date
WO2018144093A2 (fr) 2018-08-09

Similar Documents

Publication Publication Date Title
WO2018144093A3 (fr) Formulations pour soins de la peau améliorés
AU2018240515A1 (en) Nucleic acids encoding CRISPR-associated proteins and uses thereof
WO2009086504A3 (fr) Formulations à base de collagène destinées à un soin cutané amélioré
EP4421094A3 (fr) Agents thérapeutiques ciblés et leurs utilisation
EP4406585A3 (fr) Produits d'acide nucléique et leurs procédés d'administration
SG11201808019WA (en) Edaravone formulations
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
MY188139A (en) Sodium channel modulators for the treatment of pain
IN2014CN04187A (fr)
EP4299122A3 (fr) Compositions et méthodes de traitement de maladies de la peau et des muqueuses
MX2020005247A (es) Metodos y formulaciones que permiten la modulacion de respuestas inmunitarias relacionadas con la administracion de un farmaco biofarmaceutico.
CA3030422C (fr) Excipients stabilisants pour formulations de proteines therapeutiques
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
CL2019001586A1 (es) Insulina que contiene composiciones farmacéuticas.
EP4218823A3 (fr) Nouveaux promédicaments à base d'hormone de croissance humaine (hgh) polymère
CY1119957T1 (el) Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος
MX364800B (es) Tilmicosina de accion prolongada mejorada y el uso de la misma en el tratamiento del complejo respiratorio bovino (crb) y en el periodo de la vaca seca.
PH12018500036A1 (en) Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
EP4275746A3 (fr) Vésicules extracellulaires issues de cellules de lignée ostéoblastique, à usage thérapeutique et diagnostique
MY191980A (en) Formulations containing an extract of echinacea and linoleic acid derivatives
IN2014DN03213A (fr)
MX2016015211A (es) Formulaciones topicas y usos de las mismas.
EP4420722A3 (fr) Facteurs de croissance des fibroblastes modifiés pour le traitement de troubles oculaires
MX379253B (es) Formulaciones de oximetazolina estabilizadas y sus usos.
WO2019098759A3 (fr) Cellule humaine transformée et son utilisation

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17895323

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载